High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up.
Virchow Klinikum, Humboldt Universität, Berlin.
W
W
Siegert
J
J
Beyer
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D018237:Germinoma / Q000188:drug therapy* / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors; D014182:Transplantation, Autologous
D005047:Etoposide; D016190:Carboplatin; D007069:Ifosfamide